4.94
0.11 (2.28%)
| Penutupan Terdahulu | 4.83 |
| Buka | 5.02 |
| Jumlah Dagangan | 204,473 |
| Purata Dagangan (3B) | 285,103 |
| Modal Pasaran | 90,999,248 |
| Harga / Pendapatan (P/E Ke hadapan) | 10.44 |
| Harga / Jualan (P/S) | 0.980 |
| Harga / Buku (P/B) | 0.760 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Mar 2025 - 31 Mar 2025 |
| Margin Keuntungan | -27.41% |
| Margin Operasi (TTM) | -5.03% |
| EPS Cair (TTM) | -1.34 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 30.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 31.20% |
| Nisbah Semasa (MRQ) | 3.23 |
| Aliran Tunai Operasi (OCF TTM) | -1.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 8.35 M |
| Pulangan Atas Aset (ROA TTM) | -3.27% |
| Pulangan Atas Ekuiti (ROE TTM) | -20.97% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Bercampur | Menurun |
| Health Information Services (Global) | Bercampur | Menurun | |
| Stok | OptimizeRx Corporation | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.20 |
|
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 13.29% |
| % Dimiliki oleh Institusi | 68.94% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 16.00 (Roth MKM, 223.89%) | Beli |
| Median | 8.00 (61.94%) | |
| Rendah | 5.00 (Barclays, 1.22%) | Pegang |
| Purata | 9.19 (86.03%) | |
| Jumlah | 6 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 4.39 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| B. Riley Securities | 24 Dec 2024 | 13.00 (163.16%) | Beli | 4.94 |
| Lake Street | 24 Dec 2024 | 11.00 (122.67%) | Beli | 4.94 |
| Stephens & Co. | 20 Dec 2024 | 5.50 (11.34%) | Pegang | 4.91 |
| Barclays | 14 Nov 2024 | 5.00 (1.21%) | Pegang | 4.06 |
| JMP Securities | 14 Nov 2024 | 8.00 (61.94%) | Beli | 4.06 |
| RBC Capital | 14 Nov 2024 | 7.00 (41.70%) | Beli | 4.06 |
| Roth MKM | 14 Nov 2024 | 16.00 (223.89%) | Beli | 4.06 |
| Stifel | 14 Nov 2024 | 8.00 (61.94%) | Beli | 4.06 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FEBBO WILLIAM J | 4.93 | - | 20,000 | 98,600 |
| Jumlah Keseluruhan Kuantiti Bersih | 20,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 98,600 | |||
| Purata Pembelian Keseluruhan ($) | 4.93 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| FEBBO WILLIAM J | Pegawai | 12 Dec 2024 | Beli (+) | 20,000 | 4.93 | 98,600 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 23 Dec 2024 | Pengumuman | OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO |
| 18 Nov 2024 | Pengumuman | OptimizeRx to Participate in Upcoming Investor Conferences |
| 13 Nov 2024 | Pengumuman | OptimizeRx Reports Third Quarter 2024 Financial Results |
| 31 Oct 2024 | Pengumuman | OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |